JAK2 mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms

T Nageswara Rao, N Hansen, J Hilfiker, S Rai, JM Majewska, D Lekovic, D Gezer, N Andina, S Galli, T Cassel, F Geier, J Delezie, R Nienhold, H Hao-Shen, C Beisel, S Di Palma, Sarah Dimeloe, J Trebicka, D Wolf, M GassmannTW Fan, AN Lane, C Handschin, S Dirnhofer, N Kroger, Christoph Hess, T Radimerski, S Koschmieder, VP Cokic, RC SkodaShow 10 moreShow less